3-(2,4-Dimethoxybenzyl)dihydropyrimidine-2,4(1H,3H)-dione

Catalog No. :
ACSUHL465
CAS No. :
2490430-37-8
Molecular Formula :
C13H16N2O4
Molecular Weight :
264.28

IUPAC Name:3-(2,4-dimethoxybenzyl)dihydropyrimidine-2,4(1H,3H)-dione

3-(2,4-Dimethoxybenzyl)dihydropyrimidine-2,4(1H,3H)-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$50.00Login to see priceIn stockIn stock
5g95%$152.00Login to see priceIn stockIn stock
10g95%$252.00Login to see priceIn stockInquiry
25g95%$480.00Login to see priceIn stockInquiry
100g95%$1542.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(2,4-Dimethoxybenzyl)dihydropyrimidine-2,4(1H,3H)-dione
IUPAC Name3-(2,4-dimethoxybenzyl)dihydropyrimidine-2,4(1H,3H)-dione
MDL No.MFCD32852436
Molecular FormulaC13H16N2O4
Molecular Weight264.28
SMILESO=C1N(CC2=CC=C(OC)C=C2OC)C(CCN1)=O
InChI KeyIFYQFWREGGSCCG-UHFFFAOYSA-N
Synonym3-[(2,4-dimethoxyphenyl)methyl]hexahydropyrimidine-2,4-dione;2,4(1H,3H)-Pyrimidinedione, 3-[(2,4-dimethoxyphenyl)methyl]dihydro-
CAS No.2490430-37-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364

Synthetic Route by SureRoute

1. ACSUHL465 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAVRB702 route compound structure diagram
    ACAVRB7027314-44-5 In Stock
  2. Plus
  3. ACDXQY760 route compound structure diagram
    ACDXQY760504-07-4 In Stock
  4. Then
  5. ACSUHL465 route product structure diagram
    ACSUHL4652490430-37-8 In Stock
Inquiry

2. ACSUHL465 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSUHL465 route product structure diagram
    ACSUHL4652490430-37-8 In Stock
Inquiry

Comments (0)